PMS66 EARLY AND SUSTAINED REMISSION ASSOCIATED WITH NORMALIZED PHYSICAL FUNCTION AND HEALTH-RELATED QUALITY OF LIFE AND SIGNIFICANTLY IMPROVED PRODUCTIVITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH GOLIMUMAB: TWO YEAR DATA FROM THE PHASE III GO-REVEAL CLINICAL TRIAL
Title:
PMS66 EARLY AND SUSTAINED REMISSION ASSOCIATED WITH NORMALIZED PHYSICAL FUNCTION AND HEALTH-RELATED QUALITY OF LIFE AND SIGNIFICANTLY IMPROVED PRODUCTIVITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH GOLIMUMAB: TWO YEAR DATA FROM THE PHASE III GO-REVEAL CLINICAL TRIAL
Author:
Kavanaugh, A. McInnes, I. Krueger, G.G. Gladman, D. Beutler, A. Gathany, T. Mudivarthy, S. Mack, M. Tandon, N. Han, C. Mease, P.
Appeared in:
Value in health
Paging:
Volume 14 (2011) nr. 3 pages 1 p.
Year:
2011
Contents:
Publisher:
International Society for Pharmacoeconomics and Outcomes Research (ISPOR)